Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

Overview of attention for article published in BMC Neuroscience, March 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#42 of 1,303)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
twitter: 5 X users
patent: 1 patent

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 378 Dimensions

Readers on

mendeley: 297 Mendeley

Summary News X Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 1 news story.

Glucagon-like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth

Touch ENDOCRINOLOGY, 23 May 2023

1. Shah AS, Nadeau KJ, Dabelea D, Redondo MJ. Spectrum of phenotypes and causes of type 2 diabetes in children.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.